富安达医药创新混合(011383)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
91,683,300 |
- |
104,298,000 |
103,847,000 |
88% |
2023/12/31 |
114,946,000 |
- |
133,864,000 |
127,096,000 |
90% |
2023/9/30 |
121,871,000 |
- |
134,620,000 |
132,717,000 |
92% |
2023/6/30 |
123,794,000 |
- |
145,564,000 |
144,925,000 |
85% |
2023/3/31 |
150,432,000 |
- |
164,671,000 |
163,210,000 |
92% |
2022/12/31 |
141,349,000 |
- |
161,162,000 |
157,782,000 |
90% |
2022/9/30 |
119,049,000 |
- |
144,758,000 |
143,282,000 |
83% |
2022/6/30 |
153,629,000 |
- |
170,235,000 |
168,479,000 |
91% |
2022/3/31 |
140,227,000 |
- |
169,170,000 |
167,938,000 |
84% |
2021/12/31 |
196,570,000 |
- |
222,358,000 |
218,181,000 |
90% |
2021/9/30 |
204,168,000 |
- |
239,979,000 |
238,638,000 |
86% |
2021/6/30 |
252,006,000 |
- |
294,154,000 |
270,480,000 |
93% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。